Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Internal Medicine
Tocilizumab
Questions discussed in this category
How would you approach a patient with GCA who develops necrotizing fasciitis and then flares because they are off of tocilizumab?
How would you treat? Would you view tocilizumab as an option in the future?
1 Answer available
What is your approach to management of elevated liver enzymes in patients who recently started treatment with tocilizumab?
1 Answer available
How long do you continue steroid-sparing agents such as tocilizumab for GCA once the disease is in remission off steroids?
1 Answer available
At what point in GCA management do you typically introduce tocilizumab?
2 Answers available
Is there a role for tocilizumab in treatment of polymyalgia rheumatica in patients who do not have features of giant cell arteritis or rheumatoid arthritis?
1 Answer available
17339
14961
8388
8479
7868
Papers discussed in this category
,
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
Ann Intern Med, 2020 Sep 22
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.
N Engl J Med,
Trial of Tocilizumab in Giant-Cell Arteritis.
Lancet, 2016 Mar 04
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Related Topics in Internal Medicine
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers